Ledger.Open graph →
SEC Form D · filed April 14, 2021

C2i Genomics, Inc

Offering
$100.0M
Sold
$50.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Ezra Sofer · Cresskill, NJExec · DirectorEli Casdin · New York, NYDirectorAsaf Zviran · Closter, NJExec · DirectorShaun Rodriguez · New York, NYDirectorJeremy Kaufman · Columbia, MDExec · DirectorJohn Schveibinz · Columbia, MDDirectorJoseph Harsanyi · Columbia, MDExec · DirectorSuneil Jhamb · MILL VALLEY, CADirectorAlex Parker · Boston, MADirectorJose M. Sosa Del Valle · New York, NYDirectorKirk M. Beaton · New York, NYExec · DirectorVictor L. Wu · New York, NYExec · DirectorLee J. Tesconi · New York, NYDirectorAlex Parker · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗